{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:24:03Z","timestamp":1790522643215,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.neuropharm.2016.10.016","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T21:14:57Z","timestamp":1476825297000},"page":"109-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Block of voltage-gated calcium channels by peptide toxins"],"prefix":"10.1016","volume":"127","author":[{"given":"Emmanuel","family":"Bourinet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2016.10.016_bib1","doi-asserted-by":"crossref","first-page":"12566","DOI":"10.1021\/bi00210a003","article-title":"Toxityping rat brain calcium channels with \u03c9-toxins from spider and cone snail venoms","volume":"32","author":"Adams","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib2","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1074\/jbc.M209969200","article-title":"Omega-conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals","volume":"278","author":"Adams","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib3","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.bbamem.2013.01.019","article-title":"Mechanisms of conotoxin inhibition of N-type (Ca(v)2.2) calcium channels","volume":"1828","author":"Adams","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib4","first-page":"274","article-title":"Ziconotide, a new N-Type calcium channel blocker, administered intrathecally for acute postoperative pain","volume":"25","author":"Antanassoff","year":"2000","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/mol.109.058834","article-title":"Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels","volume":"77","author":"Berecki","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuropharm.2016.10.016_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1756-6606-7-36","article-title":"Block of T-type calcium channels by Protoxins I and II","volume":"2014","author":"Bladen","year":"2014","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib7","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1523\/JNEUROSCI.14-08-05011.1994","article-title":"\u03c9-Conotoxin block of N-type calcium channels in frog and rat sympathetic neurons","volume":"14","author":"Boland","year":"1994","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib8","first-page":"175","article-title":"Targeting voltage sensors in sodium channels with spider toxins","volume":"31","author":"Bosmans","year":"2010"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/8070","article-title":"Splicing of \u03b11A subunit gene generates phenotypic variants of P- and Q-type calcium channels","volume":"2","author":"Bourinet","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-3495(01)75681-0","article-title":"Interaction of SNX482 with domains III and IV inhibits activation gating of \u03b11E (Cav2.3) calcium channels","volume":"81","author":"Bourinet","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1152\/physrev.00023.2013","article-title":"Calcium permeable ion channels in pain signaling","volume":"94","author":"Bourinet","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib12","doi-asserted-by":"crossref","first-page":"10943","DOI":"10.1523\/JNEUROSCI.3594-08.2008","article-title":"Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation","volume":"28","author":"Callaghan","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/chan.4.1.10281","article-title":"Analgesic alpha-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of alpha9 nicotinic receptor knockout mice","volume":"4","author":"Callaghan","year":"2010","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib14","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.2174\/138161211798999401","article-title":"Engineering of conotoxins for the treatment of pain","volume":"17","author":"Carstens","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib15","article-title":"\u03b1-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors","author":"Castro","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/pr.57.4.5","article-title":"International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.neuron.2010.08.021","article-title":"Ion channel voltage sensors: structure, function, and pathophysiology","volume":"67","author":"Catterall","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib18","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/3669","article-title":"Inhibition of T-type voltage-gated calcium channels by a new scorpion toxin","volume":"1","author":"Chuang","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib19","doi-asserted-by":"crossref","first-page":"23254","DOI":"10.1074\/jbc.M604550200","article-title":"The synthesis, structural characterization, and receptor specificity of the alpha-conotoxin Vc1.1","volume":"281","author":"Clark","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib20","doi-asserted-by":"crossref","first-page":"23948","DOI":"10.1074\/jbc.M112.342998","article-title":"gamma-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic alpha-conotoxins","volume":"287","author":"Cuny","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib21","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1073\/pnas.88.6.2437","article-title":"Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel","volume":"88","author":"de Weille","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib22","doi-asserted-by":"crossref","DOI":"10.1113\/JP272262","article-title":"Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology","author":"Dolphin","year":"2016","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.toxicon.2010.06.009","article-title":"Inhibition of the activation pathway of the T-type calcium channel Ca(V)3.1 by ProTxII","volume":"56","author":"Edgerton","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/372272a0","article-title":"Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin","volume":"372","author":"Ellinor","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib25","doi-asserted-by":"crossref","first-page":"8748","DOI":"10.1021\/bi9602674","article-title":"A\u00a0novel hydrophobic omega-conotoxin blocks molluscan dihydropyridine-sensitive calcium channels","volume":"35","author":"Fainzilber","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib26","doi-asserted-by":"crossref","first-page":"15728","DOI":"10.1074\/jbc.M100406200","article-title":"Residue Gly1326 of the N-type calcium channel alpha 1B subunit controls reversibility of \u03c9-conotoxin GVIA and MVIIA block","volume":"276","author":"Feng","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib27","doi-asserted-by":"crossref","first-page":"20171","DOI":"10.1074\/jbc.M300581200","article-title":"Determinants of inhibition of transiently expressed voltage-gated calcium channels by \u03c9-conotoxins GVIA and MVIIA","volume":"278","author":"Feng","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/BF00374813","article-title":"Irreversible and reversible blockade of IMR32 calcium channel currents by synthetic MVIIA and iodinated MVIIC \u03c9-conopeptides","volume":"429","author":"Fox","year":"1995","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00232-001-0080-7","article-title":"Calciseptine, a Ca2+ channel blocker, has agonist actions on L-type Ca2+ currents of frog and mammalian skeletal muscle","volume":"184","author":"Garc\u00eda","year":"2001","journal-title":"J.\u00a0Mem. Biol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0028-3908(94)90017-5","article-title":"\u03c9-conotoxin MVIIC reversibly inhibits a human N-type calcium channel and calcium influx into chick synaptosomes","volume":"33","author":"Grantham","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib31","doi-asserted-by":"crossref","first-page":"32453","DOI":"10.1074\/jbc.M313825200","article-title":"The first gamma-carboxyglutamic acid-containing contryphan. A selective L-type calcium ion channel blocker isolated from the venom of Conus marmoreus","volume":"279","author":"Hansson","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0896-6273(92)90221-X","article-title":"A\u00a0new Conus peptide ligand for mammalian presynaptic Ca2+ channels","volume":"9","author":"Hillyard","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1124\/mol.114.096156","article-title":"Novel mechanism of voltage-gated N-type (Cav2.2) calcium channel inhibition revealed through \u03b1-conotoxin Vc1.1 activation of the GABA(B) receptor","volume":"87","author":"Huynh","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib34","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1152\/physrev.00002.2006","article-title":"Voltage-gated calcium channels and the idiopathic generalized epilepsies","volume":"86","author":"Khosravani","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib35","first-page":"9182","article-title":"Inhibition of A-type potassium current by the peptide toxin SNX-482","volume":"34","author":"Kimm","year":"2014"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pain.2010.09.007","article-title":"A\u00a0novel mechanism of inhibition of high-voltage activated calcium channels by \u03b1-conotoxins contributes to relief of nerve injury-induced neuropathic pain","volume":"152","author":"Klimis","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0026-895X(25)13204-5","article-title":"Isolation and pharmacological characterization of \u03c9-grammotoxin SIA, a novel peptide inhibitor of neuronal voltage-sensitive calcium channel responses","volume":"44","author":"Lampe","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1085\/jgp.88.3.321","article-title":"Blockade of current through single calcium channels by Cd2+, Mg2+, and Ca2+. Voltage and concentration dependence of calcium entry into the pore","volume":"88","author":"Lansman","year":"1986","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib39","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1744-8069-6-97","article-title":"Analgesic effect of highly reversible omega-conotoxin FVIA on N type Ca2+ channels","volume":"6","author":"Lee","year":"2010","journal-title":"Mol. Pain"},{"issue":"9","key":"10.1016\/j.neuropharm.2016.10.016_bib108","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/bi201633j","article-title":"Solution structure of kurtoxin: a gating modifier selective for Cav3 voltage-gated Ca(2+) channels","volume":"51","author":"Lee","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/pr.111.005322","article-title":"Conus venom peptide pharmacology","volume":"64","author":"Lewis","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib41","doi-asserted-by":"crossref","first-page":"35335","DOI":"10.1074\/jbc.M002252200","article-title":"Novel \u03c9-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes","volume":"275","author":"Lewis","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib42","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1073\/pnas.86.5.1689","article-title":"Blocking and isolation of a calcium channel from neurons in mammals and cephalopods utilizing a toxin fraction (FTX) from funnel-web spider poison","volume":"86","author":"Llinas","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib43","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1073\/pnas.84.12.4327","article-title":"\u03c9-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle","volume":"84","author":"McCleskey","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib44","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0006-3495(97)78854-4","article-title":"Alteration of P-type calcium channel gating by the spider toxin \u03c9-Aga-IVA","volume":"72","author":"McDonough","year":"1997","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib45","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1124\/mol.52.6.1095","article-title":"Voltage-dependent inhibition of N- and P-type calcium channels by the peptide toxin \u03c9-grammotoxin-SIA","volume":"52","author":"McDonough","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1085\/jgp.20028560","article-title":"Interactions among toxins that inhibit N-type and P-type calcium channels","volume":"119","author":"McDonough","year":"2002","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib47","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1523\/JNEUROSCI.19-17-07268.1999","article-title":"Properties of Q-type calcium channels in neostriatal and cortical neurons are correlated with beta subunit expression","volume":"19","author":"Mermelstein","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib48","doi-asserted-by":"crossref","first-page":"14734","DOI":"10.1021\/bi026546a","article-title":"Two tarantula peptides inhibit activation of multiple sodium channels","volume":"41","author":"Middleton","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib49","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.2174\/0929867043363884","article-title":"Ziconotide: neuronal calcium channel blocker for treating severe chronic pain","volume":"11","author":"Miljanich","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib50","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1073\/pnas.88.15.6628","article-title":"Inhibition of N- and L-type Ca2+ channels by the spider venom toxin \u03c9-Aga-IIIA","volume":"88","author":"Mintz","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib51","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/355827a0","article-title":"P-type calcium channels blocked by the spider toxin \u03c9-Aga-IVA","volume":"355","author":"Mintz","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib52","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1523\/JNEUROSCI.14-05-02844.1994","article-title":"Block of Ca channels in rat central neurons by the spider toxin \u03c9-Aga-IIIA","volume":"14","author":"Mintz","year":"1994","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib53","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0028-3908(93)90008-Q","article-title":"A\u00a0new Conus peptide ligand for Ca channel subtypes","volume":"32","author":"Monje","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib54","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1460-9568.2006.05299.x","article-title":"Omega-conotoxin CVIB differentially inhibits native and recombinant N- and P\/Q-type calcium channels","volume":"25","author":"Motin","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib55","doi-asserted-by":"crossref","first-page":"34705","DOI":"10.1074\/jbc.M310848200","article-title":"The a2\u03b4 auxiliary subunit reduces affinity of \u03c9-conotoxins for recombinant N-type calcium channels","volume":"279","author":"Mould","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib56","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/mol.107.040568","article-title":"Are alpha9alpha10 nicotinic acetylcholine receptors a pain target for alpha-conotoxins?","volume":"72","author":"Nevin","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib57","doi-asserted-by":"crossref","first-page":"15353","DOI":"10.1021\/bi981255g","article-title":"Selective peptide antagonist of the class E calcium channel from the venom of the tarantula Hysterocrates gigas","volume":"37","author":"Newcomb","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib58","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1021\/bi00026a015","article-title":"SNX-325, a novel calcium antagonist from the spider Segestria florentina","volume":"34","author":"Newcomb","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/jmbi.1996.0576","article-title":"A\u00a0consensus structure for \u03c9-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: comparison of MVIIA, SVIB and SNX-202","volume":"263","author":"Nielsen","year":"1996","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib60","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1254\/jphs.09356FP","article-title":"Tarantula toxin ProTx-I differentiates between human T-type voltage-gated Ca2+ channels Cav3.1 and Cav3.2","volume":"112","author":"Ohkubo","year":"2010","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib61","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0006-291X(02)02706-7","article-title":"Two new scorpion toxins that target voltage-gated Ca2+ and Na+ channels","volume":"299","author":"Olamendi-Portugal","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib62","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.4071055","article-title":"Peptide neurotoxins from fish-hunting cone snails","volume":"230","author":"Olivera","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib63","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1021\/bi00382a004","article-title":"Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using \u03c9-conotoxin from Conus magus venom","volume":"26","author":"Olivera","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib64","doi-asserted-by":"crossref","first-page":"22067","DOI":"10.1016\/S0021-9258(18)54531-2","article-title":"Conotoxins","volume":"266","author":"Olivera","year":"1991","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib65","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1146\/annurev.bi.63.070194.004135","article-title":"Calcium channel diversity and neurotransmitter release: the \u03c9-conotoxins and \u03c9-agatoxins","volume":"63","author":"Olivera","year":"1994","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib66","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0041-0101(00)00150-1","article-title":"The effect of Huwentoxin-I on Ca(2+) channels in differentiated NG108-15 cells, a patch-clamp study","volume":"39","author":"Peng","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib67","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0304-3959(99)00254-7","article-title":"Adverse effects associated with the intrathecal administration of ziconotide","volume":"85","author":"Penn","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib68","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00374774","article-title":"\u03c9-Grammotoxin blocks action-potential-induced Ca2+ influx and whole-cell Ca2+ current in rat dorsal-root ganglion neurons","volume":"426","author":"Piser","year":"1994","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib69","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0026-895X(25)10037-0","article-title":"\u03c9-grammotoxin SIA blocks multiple, voltage-gated, Ca2+ channel subtypes in cultured rat hippocampal neurons","volume":"48","author":"Piser","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/368067a0","article-title":"Calcium channel beta-subunit binds to a conserved motif in the I-II cytoplasmic linker of the alpha1-subunit","volume":"368","author":"Pragnell","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib71","doi-asserted-by":"crossref","first-page":"9919","DOI":"10.1021\/bi00156a009","article-title":"Novel \u03b1- and \u03c9-conotoxins from Conus striatus venom","volume":"31","author":"Ramilo","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib72","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1523\/JNEUROSCI.15-04-02995.1995","article-title":"Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons","volume":"15","author":"Randall","year":"1995","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib73","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1744-8069-9-51","article-title":"Novel \u03c9-conotoxins from C. catus reverse signs of mouse inflammatory pain after systemic administration","volume":"9","author":"Sadeghi","year":"2013","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib74","doi-asserted-by":"crossref","first-page":"23894","DOI":"10.1038\/srep23894","article-title":"Molecular interactions between Tarantula toxins and low-voltage-activated calcium channels","volume":"6","author":"Salari","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib75","doi-asserted-by":"crossref","first-page":"20701","DOI":"10.1016\/S0021-9258(19)36742-0","article-title":"Heterodimeric structure of the spider toxin \u03c9-agatoxin IA revealed by precursor analysis and mass spectrometry","volume":"267","author":"Santos","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib76","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1124\/mol.108.047670","article-title":"ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors","volume":"74","author":"Schmalhofer","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib77","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/157340606778250216","article-title":"N-type calcium channel blockers: novel therapeutics for the treatment of pain","volume":"2","author":"Schroeder","year":"2006","journal-title":"Med. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib78","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1073\/pnas.91.3.878","article-title":"Calcicludine, a venom peptide of the Kunitz-type protease inhibitor family, is a potent blocker of high-threshold Ca2+ channels with a high affinity for L-type channels in cerebellar granule neurons","volume":"91","author":"Schweitz","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib79","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-2999(02)02247-1","article-title":"Actions of intrathecal \u03c9-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat","volume":"451","author":"Scott","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib80","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1523\/JNEUROSCI.20-19-07174.2000","article-title":"Low-affinity blockade of neuronal N-type Ca channels by the spider toxin \u03c9-agatoxin-IVA","volume":"20","author":"Sidach","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib81","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1523\/JNEUROSCI.22-06-02023.2002","article-title":"Kurtoxin, a gating modifier of neuronal high- and low-threshold Ca channels","volume":"22","author":"Sidach","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib82","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuron.2014.03.016","article-title":"Neuronal voltage gated calcium channels: structure, function and dysfunction","volume":"82","author":"Simms","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib83","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib84","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1523\/JNEUROSCI.17-09-03002.1997","article-title":"Preferential interaction of omega-conotoxins with inactivated N-Type Ca2+ channels","volume":"17","author":"Stocker","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s002320001040","article-title":"Block of voltage-dependent calcium channel by the green mamba toxin calcicludine","volume":"174","author":"Stotz","year":"2000","journal-title":"J.\u00a0Membr. Biol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib86","first-page":"147","article-title":"Treatment challenges and complications with Ziconotide monotherapy in established pump patients","volume":"9","author":"Thompson","year":"2006","journal-title":"Pain Physician"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib87","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1126\/science.1357749","article-title":"Calcium channels coupled to glutamate release identified by \u03c9-Aga-IVA","volume":"258","author":"Turner","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib88","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0026-895X(25)08546-3","article-title":"Characterization of presynaptic calcium channels with \u03c9-conotoxin MVIIC and \u03c9-grammotoxin SIA: role for a resistant calcium channel type in neurosecretion","volume":"47","author":"Turner","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib89","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1016\/S0021-9258(18)45925-X","article-title":"Antagonism of synaptosomal calcium channels by subtypes of omega-agatoxins","volume":"267","author":"Venema","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1525-1403.2008.00150.x","article-title":"An open-label, multicenter study of the safety and efficacy of intrathecal ziconotide for severe chronic pain when delivered via an external pump","volume":"11","author":"Ver","year":"2008","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib91","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-1403.2006.00055.x","article-title":"Intrathecal Ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial","volume":"9","author":"Wallace","year":"2006","journal-title":"Neuromodulation"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib92","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1021\/bi7001696","article-title":"Calcicludine binding to the outer pore of L-type calcium channels is allosterically coupled to dihydropyridine binding","volume":"46","author":"Wang","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib93","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuropharm.2015.08.047","article-title":"Molecular basis of toxicity of N-type calcium channel inhibitor MVIIA","volume":"101","author":"Wang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib94","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nn.3602","article-title":"Regulating excitability of peripheral afferents: emerging ion channel targets","volume":"17","author":"Waxman","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib95","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1085\/jgp.116.5.637","article-title":"A\u00a0hot spot for the interaction of gating modifier toxins with voltage-dependent ion channels","volume":"116","author":"Winterfield","year":"2000","journal-title":"J.\u00a0Gen. Physiol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib96","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1006\/mcne.1994.1042","article-title":"Calcium channel subtypes in rat brain: biochemical characterization of the high-affinity receptors for \u03c9-conopeptides SNX-230 (synthetic MVIIC), SNX-183 (SVIB), and SNX-111 (MVIIA)","volume":"5","author":"Woppmann","year":"1994","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib97","doi-asserted-by":"crossref","first-page":"22347","DOI":"10.1016\/S0021-9258(17)31796-9","article-title":"Structure and functional characterization of neuronal \u03b11E calcium channel subtypes","volume":"269","author":"Williams","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib98","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1126\/science.aad2395","article-title":"Structure of the voltage-gated calcium channel Cav1.1 complex","volume":"350","author":"Wu","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib99","doi-asserted-by":"crossref","DOI":"10.1038\/nature19321","article-title":"Structure of the voltage-gated calcium channel Cav1.1 at 3.6 A resolution","author":"Wu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib100","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0022-3565(25)10579-X","article-title":"Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats","volume":"274","author":"Xiao","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib101","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/mol.110.066332","article-title":"The tarantula toxins ProTx-II and huwentoxin-IV differentially interact with human Nav1.7 voltage sensors to inhibit channel activation and inactivation","volume":"78","author":"Xiao","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib102","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1006\/bbrc.1993.1862","article-title":"Calciseptine binding to a 1,4-dihydropyridine recognition site of the L-type calcium channel of rat synaptosomal membranes","volume":"194","author":"Yasuda","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib103","first-page":"287","article-title":"FS2. a mamba venom toxin, is a specific blocker of the L-type calcium channels","volume":"21","author":"Yasuda","year":"1994","journal-title":"Artery"},{"key":"10.1016\/j.neuropharm.2016.10.016_bib104","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1111\/j.1460-9568.2004.03810.x","article-title":"Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance","volume":"20","author":"Yokoyama","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib105","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pharmacology and pathology of voltage-gated calcium channels and their therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib106","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2015.5","article-title":"Targeting voltage-gated calcium channels in neurological and psychiatric diseases","volume":"15","author":"Zamponi","year":"2016","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.neuropharm.2016.10.016_bib107","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00210-008-0385-5","article-title":"Actions of kurtoxin on tetrodotoxin-sensitive voltage-gated Na+ currents, NaV1.6, in murine vas deferens myocytes","volume":"379","author":"Zhu","year":"2009","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081630466X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081630466X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:47:52Z","timestamp":1758437272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081630466X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":108,"alternative-id":["S002839081630466X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.10.016","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Block of voltage-gated calcium channels by peptide toxins","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}